Leaderboard
Insiders and issuers ranked by realized signed return on open-market Form 4 trades. Returns are signed: a sale followed by a rally counts against the seller.
What the metrics mean
Return - the insider's signed return per trade, averaged. A +10% stock move on a buy scores +10%; on a sell, -10%. Because most insider activity is concentrated at rallying stocks, this metric correlates with raw stock performance and doesn't fully isolate timing skill from market drift.
Edge - signed return minus the stock's average forward N-day return over the same period. An insider with +5% edge consistently chose better days to trade than someone who'd picked a random day in the same window. Isolates timing skill from "the stock just went up."
Neither metric is the same as ranking stocks by raw return - that would just surface the best-performing tickers, which you can get from any market screener.
Issuers ranked
2,418
Showing 50 of 2,418
Quality filters
10+ trades
≥3 insiders, 50% price coverage
Window
5y trailing
Trade date filter
| # | Ticker | Issuer | Trades | Insiders | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|---|---|
| 1 | MULN | Mullen Automotive Inc. | 20/32 | 10 | 100% | +82.6% | +93.9% | +100.0% | +41.4% |
| 2 | CTNT | Cheetah Net Supply Chain Service Inc. | 11 | 6 | 100% | +81.4% | +80.8% | +98.0% | +64.5% |
| 3 | CERO | Cero Therapeutics Holdings, Inc. | 29 | 5 | 100% | +79.3% | +83.2% | +87.3% | +38.0% |
| 4 | TTOO | T2 Biosystems, Inc. | 171 | 11 | 99% | +78.4% | +77.8% | +88.5% | -6.5% |
| 5 | BBGI | Beasley Broadcast Group Inc | 10 | 4 | 100% | +76.1% | +76.1% | +76.1% | +76.1% |
| 6 | MICS | Singing MacHine Co Inc | 26/29 | 6 | 85% | +69.6% | +82.5% | +87.9% | -4.4% |
| 7 | NTHI | Neonc Technologies Holdings, Inc. | 21 | 5 | 100% | +67.6% | +69.4% | +69.4% | +30.7% |
| 8 | SRM | Srm Entertainment, Inc. | 34/36 | 6 | 97% | +65.8% | +73.6% | +73.6% | -10.9% |
| 9 | MYSZ | My Size, Inc. | 14 | 5 | 100% | +64.5% | +67.6% | +70.7% | +40.9% |
| 10 | IONM | Assure Holdings Corp. | 29 | 3 | 100% | +63.3% | +66.4% | +80.0% | +37.4% |
| 11 | FXLV | F45 Training Holdings Inc. | 32 | 3 | 100% | +63.2% | +64.2% | +67.1% | +57.3% |
| 12 | AZTR | Azitra Inc | 54 | 18 | 100% | +63.1% | +63.1% | +63.1% | +63.1% |
| 13 | MPLN | Multiplan Corp | 54 | 9 | 100% | +62.3% | +62.3% | +62.3% | +62.3% |
| 14 | LYRA | Lyra Therapeutics, Inc. | 52 | 6 | 100% | +62.2% | +63.1% | +85.4% | +14.8% |
| 15 | ZSPC | Zspace, Inc. | 22/30 | 5 | 100% | +60.1% | +57.8% | +82.5% | +43.4% |
| 16 | WAVD | Wavedancer, Inc. | 80 | 8 | 100% | +59.0% | +59.4% | +63.6% | +51.2% |
| 17 | ASST | Asset Entities Inc. | 24 | 8 | 100% | +58.9% | +65.2% | +81.0% | +4.6% |
| 18 | LIDR | Aeye, Inc. | 39 | 8 | 100% | +58.7% | +66.0% | +82.1% | +7.9% |
| 19 | ARX | Accelerant Holdings | 12/13 | 4 | 100% | +58.4% | +58.4% | +58.4% | +58.4% |
| 20 | EFTR | Effector Therapeutics, Inc. | 102 | 11 | 100% | +56.7% | +59.4% | +71.0% | +18.9% |
| 21 | MIRA | Mira Pharmaceuticals, Inc. | 48 | 3 | 100% | +56.3% | +71.6% | +77.0% | +2.6% |
| 22 | PRST | Presto Automation Inc. | 29 | 7 | 100% | +56.1% | +54.1% | +98.0% | +1.4% |
| 23 | BNZI | Banzai International, Inc. | 31 | 3 | 100% | +55.3% | +59.7% | +60.4% | +37.8% |
| 24 | VOR | Vor Biopharma Inc. | 221/281 | 8 | 100% | +54.1% | +51.5% | +87.5% | +34.9% |
| 25 | CYCC | Cyclacel Pharmaceuticals, Inc. | 22 | 5 | 100% | +53.2% | +56.7% | +85.4% | +24.5% |
| 26 | RELI | Reliance Global Group, Inc. | 16/17 | 5 | 94% | +53.0% | +58.9% | +76.6% | -13.2% |
| 27 | IBIO | Ibio, Inc. | 17 | 3 | 100% | +52.3% | +50.7% | +78.7% | +9.4% |
| 28 | SSNT | Silversun Technologies, Inc. | 48/54 | 10 | 85% | +52.2% | +91.2% | +93.7% | -18.3% |
| 29 | EAST | Eastside Distilling, Inc. | 54/59 | 12 | 100% | +51.9% | +51.9% | +51.9% | +51.9% |
| 30 | EONR | Eon Resources Inc. | 15 | 5 | 100% | +51.9% | +52.7% | +64.6% | +38.3% |
| 31 | TPHS | Trinity Place Holdings Inc. | 21 | 3 | 100% | +51.1% | +45.2% | +72.7% | +12.2% |
| 32 | IMRX | Immuneering Corp | 52 | 4 | 100% | +50.7% | +57.5% | +57.5% | +11.5% |
| 33 | BURU | Nuburu, Inc. | 650 | 10 | 100% | +50.5% | +46.2% | +66.1% | +42.2% |
| 34 | UP | Wheels Up Experience Inc. | 18/19 | 9 | 94% | +50.5% | +54.0% | +77.3% | -36.0% |
| 35 | KZR | Kezar Life Sciences, Inc. | 21 | 4 | 90% | +50.0% | +63.4% | +65.8% | -35.6% |
| 36 | PEPG | Pepgen Inc. | 30/31 | 8 | 100% | +49.8% | +50.7% | +78.6% | +3.9% |
| 37 | SKYE | Skye Bioscience, Inc. | 100 | 13 | 100% | +49.4% | +44.2% | +63.1% | +31.8% |
| 38 | SLNH | Soluna Holdings, Inc | 68/70 | 9 | 96% | +49.3% | +53.8% | +73.2% | -12.6% |
| 39 | CDT | Conduit Pharmaceuticals Inc. | 54 | 7 | 100% | +49.1% | +55.6% | +83.4% | +23.2% |
| 40 | LOCL | Local Bounti Corporation/De | 44/46 | 8 | 93% | +47.1% | +58.3% | +66.8% | -42.1% |
| 41 | NTSK | Netskope Inc | 12 | 3 | 100% | +46.7% | +45.7% | +51.6% | +44.1% |
| 42 | BTAI | Bioxcel Therapeutics, Inc. | 74/78 | 9 | 86% | +46.6% | +59.9% | +84.7% | -5.4% |
| 43 | NMRA | Neumora Therapeutics, Inc. | 21 | 6 | 100% | +45.2% | +50.0% | +87.0% | +7.3% |
| 44 | AGBA | Agba Group Holding Ltd. | 22 | 3 | 100% | +44.8% | +41.4% | +73.8% | +24.4% |
| 45 | OGEN | Oragenics Inc | 11 | 4 | 82% | +44.5% | +55.8% | +73.6% | -5.5% |
| 46 | STKS | One Group Hospitality, Inc. | 29 | 5 | 100% | +44.5% | +45.8% | +46.6% | +14.4% |
| 47 | KERN | Akerna Corp. | 13 | 6 | 85% | +43.5% | +64.2% | +72.8% | -1.4% |
| 48 | PXMD | Paxmedica, Inc. | 50 | 5 | 92% | +43.2% | +30.9% | +90.5% | -46.4% |
| 49 | WLTH | Wealthfront Corp | 15 | 12 | 100% | +43.2% | +43.2% | +43.2% | +43.2% |
| 50 | MGNX | MacRogenics Inc | 19 | 6 | 84% | +42.8% | +76.4% | +79.7% | -58.5% |
Showing 1-50 of 2,418